A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 366-369, 2015.
Article
在 En
| WPRIM
| ID: wpr-223601
Responsible library:
WPRO
ABSTRACT
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events are common. A 74-year-old female with metastatic GIST who was managed with imatinib experienced severe adverse events, including skin rashes, tremor, and alopecia, etc. The imatinib dose was reduced and the size of the metastatic GIST continued to decrease and adverse events showed significant improvement.
Key words
全文:
1
索引:
WPRIM
主要主题:
Immunohistochemistry
/
Tomography, X-Ray Computed
/
Proto-Oncogene Proteins c-kit
/
Gastrointestinal Stromal Tumors
/
Exanthema
/
Imatinib Mesylate
/
Gastrointestinal Neoplasms
/
Antineoplastic Agents
限制:
Aged
/
Female
/
Humans
语言:
En
期刊:
The Korean Journal of Gastroenterology
年:
2015
类型:
Article